- $146.43bn
- $205.91bn
- $58.50bn
- 67
- 66
- 48
- 63
Pfizer Inc - Statement Regarding Webcast Invite
AnnouncementPfizer Inc - Pfizer Launches Global Regenerative Medicine Research Unit
AnnouncementPfizer Inc Pfizer Reports Second-Quarter 2009
AnnouncementPfizer Inc Pfizer Reports Second-Quarter 2009
AnnouncementPfizer Inc - Pfizer launches online pipeline
AnnouncementPfizer Inc - Research Update
AnnouncementPfizer Inc - Pfizer Wins Celebrex Patent Challenge by Generic Manufacturer Teva
AnnouncementPfizer Inc - Pfizer and Transtech
AnnouncementPfizer Inc - Pfizer Analyst Meeting
AnnouncementPfizer Inc. Two Phase 3 Trials Of Sunitinib With Commonly Used Chemotherapies In
AnnouncementPfizer Inc. Pfizer Discontinues A Phase 3 Study Of Figitumumab In Previously Tre
AnnouncementPfizer Inc - Pfizer Invites Public to View and Listen to Webcast of Pfizer Parti
AnnouncementPfizer Inc - Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Co
AnnouncementPfizer Inc Pfizer Provides U.S. Regulatory Update On Prevnar 13tm Vaccine
AnnouncementPfizer Inc Pfizer, Kano State Reach Settlement Of Trovan Cases
AnnouncementPfizer Inc - Pfizer Invites Public to View and Listen to Webcast of March 5 Meet
AnnouncementPfizer Inc - Statement re: Pfizer Lipitor patent in Australia
AnnouncementPfizer Inc - Petitions Filed
AnnouncementPfizer Inc Pfizer And Medivation Initiate Phase 3 Trial Of Dimebon In Patients W
Announcement